Andrew Mitchell suggests that innovative institutional changes are needed to sustain universal healthcare in Canada.

Françoise Baylis wonders how it is that in 14 months (from December 2015 to February 2017), the U.S. National Academy of Sciences and the U.S. National Academy of Medicine have moved human germline genome editing out of the category ‘irresponsible’ and into the category ‘permissible.’

Ryan Tanner responds to objections to allowing medical assistance in dying for persons suffering from mental illness as the sole underlying medical condition.

Jean-Christophe Bélisle-Pipon and Stanislav Birko consider how direct-to-consumer marketing of prescription drugs using social media might be prevented by amending Canada’s Food and Drug Regulations.

Alice Dreger raises concerns about a pervasive pattern of non-evidence based assumptions driving practices in pediatric endocrinology.

Janet Farrell Leontiou reflects on her experience as an IVF patient who was misled into choosing several multiple embryo transfers.

Andrew Fenton and Letitia Meynell call for moral reflection on the primacy of capacities for determining the moral status of non-human animals used in human-animal chimera research.